| 前收市價 | 1,937.50 |
| 開市 | 1,960.00 |
| 買盤 | 1,940.50 x 無 |
| 賣出價 | 1,941.00 x 無 |
| 今日波幅 | 1,927.50 - 1,960.00 |
| 52 週波幅 | 1,825.00 - 2,814.00 |
| 成交量 | |
| 平均成交量 | 133,643 |
| 市值 | 124.674B |
| Beta 值 (5 年，每月) | 0.81 |
| 市盈率 (最近 12 個月) | 23.40 |
| 每股盈利 (最近 12 個月) | 82.93 |
| 業績公佈日 | 2024年8月01日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 2,668.05 |
Insider MonkeyGenmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to […]
Investor's Business DailyGenmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover
Genmab stock slumped Wednesday after the Danish biotech announced it will buy privately held ProfoundBio for $1.8 billion.
Insider Monkey30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
